• SENSEX 80,737.51
    -636.24 (--0.78%)
  • BANKNIFTY 55,599.95
    -303.45 (--0.54%)
  • Yes Bank
    20.77 16.02(%)
  • Vodafone Idea
    6.74 6.46(%)
  • Aptus Value Hou.
    305.00 267.75(%)
  • TCS
    3,399.40 3,060.25(%)
  • Larsen & Toubro
    3,617.00 2,967.65(%)
  • Eternal Ltd
    236.80 146.85(%)
  • Zinka Logistics
    451.35 548.00(%)
  • M & M
    3,065.15 3,276.30(%)
  • HDFC Bank
    1,920.00 1,452.85(%)
  • Garden Reach Sh.
    3,188.75 3,188.75(%)
  • Cochin Shipyard
    2,049.70 2,977.10(%)
  • Reliance Industr
    1,403.00 1,115.55(%)
  • Suzlon Energy
    67.95 45.13(%)
  • Kotak Mah. Bank
    2,033.40 1,602.20(%)
  • Brainbees Solut.
    393.00 734.25(%)
  • Infosys
    1,535.35 1,307.10(%)
  • ICICI Bank
    1,431.75 1,051.50(%)
  • Bharti Airtel
    1,831.75 1,224.50(%)
  • Reliance Power
    58.50 23.26(%)
  • Axis Bank
    1,175.00 934.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Beryl Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3982.0
  • ISIN : INE415H01017
19.29 1 (4.27%)
  • As on 03 Jun 2025 (EOD)

  • Today’s Low

    18.00

  • Today’s High

    19.40

  • Open

    18.50

  • Perv Close

    18.50

  • 52W Low

    17.35

  • 52W High

    46.00

Key Indicators

  • P/E(TTM)

    16.92

  • Mar.Cap (₹Cr.)

    9.78

  • Div & Yield %

    0.00

  • Book Value(₹)

    18.70

  • Debt-Equity Ratio

    4.27

  • AGM Date

    03-Jun-2025

  • EPS

    1.14

  • P/E Ratio

    16.92

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    9.78

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.07

  • BV (₹)

    18.70

  • Sales( ₹ in Cr.)

    21.15

  • NP (in Cr.)

    0.58

  • NP Var(%)

    -24.0

  • Div%

    0.0

  • CPS (₹)

    3.60

  • EPS (₹)

    1.10

  • Traded Value (₹ in Lakhs)

    9.78

  • 52 Week High

    46.00

  • 52 Week Low

    17.35

  • Price BSE

    19.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    9.78

  • P/C Ratio

    5.30

  • P/E Ratio

    16.60

  • Price Vs.BV

    1.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 26.73 26.89 14.60 14.09 12.82 12.96
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 26.73 26.89 14.60 14.09 12.82 12.96
Other Income 0.40 0.27 0.16 0.64 0.23 0.24
Stock Adjustments 0.17 -0.31 0.30 0.03 0.07 -0.13
Total Income 27.30 26.85 15.06 14.76 13.12 13.07
EXPENDITURE :            
Raw Materials 1.48 1.25 0.90 0.76 0.94 6.85
Power and Fuel Cost 1.54 1.27 0.85 0.86 0.77 1.06
Employee Cost 1.93 1.70 1.31 1.18 0.97 0.85
Other Manufacturing Expenses 15.01 15.78 9.03 7.90 7.04 0.90
Selling and Administration Expenses 4.28 4.50 2.18 1.92 2.24 2.06
Miscellaneous Expenses 0.28 0.07 0.20 0.06 0.02 0.10
Employee Benefit Expenses 1.93 1.70 1.31 1.18 0.97 0.85
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 24.53 24.58 14.48 12.67 11.98 11.81
Operating Profit 2.76 2.27 0.60 2.09 1.14 1.27
Interest 0.55 0.47 0.46 0.47 0.32 0.15
Gross Profit 2.21 1.80 0.14 1.62 0.82 1.12
Depreciation 1.20 0.81 1.09 1.27 0.66 0.32
Profit Before Tax 1.01 0.99 -0.95 0.35 0.16 0.80
Current Tax 0.44 0.16 0.01 0.00 -0.04 0.26
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.20 0.06 -0.30 0.11 0.15 -0.05
Reported Net Profit 0.77 0.77 -0.66 0.24 0.05 0.59
Extraordinary Items 0.01 0.00 0.00 0.34 0.00 0.01
Adjusted Net Profit 0.76 0.77 -0.66 -0.10 0.05 0.58
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 3.00 2.23 2.89 2.65 2.60 2.01
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 3.77 3.00 2.23 2.89 2.65 2.60
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.51 1.50 -1.29 0.47 0.09 1.16
Earnings Per Share(Adj)-Unit Curr 1.51 1.50 -1.29 0.47 0.09 1.16
Book Value 17.52 15.84 14.32 15.57 14.97 14.78
Book Value(Adj)-Unit Curr 17.52 15.84 14.32 15.57 14.97 14.78

Shareholding Pattern

  • Promoter Group

    26.38%

  • Public Share Holding

    73.62%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,338,135 26.38 1,338,135 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,338,135 26.38 1,338,135 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 144,378 2.85 104,678 41
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 35,786 0.71 23,986 39
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 77,629 1.53 77,629 44
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 845,502 16.67 845,502 15
Individuals holding nominal share capital up to Rs. 1 lakh 2,630,270 51.86 1,423,370 7,288
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,733,565 73.62 2,475,165 7,427
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,071,700 100.00 3,813,300 7,431

Company Background

Beryl Drugs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Beryl Drugs Ltd
  • BSE Code : 3982.0
  • ISIN : INE415H01017

  • Incorporation Year

    1993

  • Registered Office

    133 Kanchan Bag
    , Indore,
    Madhya Pradesh-452001

  • Telephone

    91-731-25076375/3046366

  • FAX

    91-731-25065375/3046366

  • Chairman

    Sudhir Sethi

  • Managing Director

    Sanjay Sethi

  • Company Secretary

    Neha Sharma

  • Auditor

    Subhash Chand Jain Anurag & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Adroit Corp. Services Pvt Ltd
    19/20 Jaferbhoy Ind,
    1st Floor Makwana Rd,Marol Naka
    Mumbai - Mumbai - 400 059

Beryl Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Beryl Drugs 19.29 27.12 26.73 16.92 11.38
Abbott India 31,061.15 6,097.18 5,848.91 46.66 44.71
Astrazeneca Phar 9,334.25 1,330.33 1,295.53 201.60 33.26
P & G Health Ltd 5,742.35 1,166.89 1,151.26 37.95 39.76
Glaxosmi. Pharma 3,223.65 3,530.73 3,407.25 59.42 44.44
Cipla 1,472.80 17,645.00 16,574.34 23.06 20.10
Amrutanjan Healt 730.95 437.58 421.23 41.58 20.84
Fermenta Biotec. 324.00 315.24 307.09 14.11 4.10
Guj. Themis Bio. 306.40 174.19 169.82 68.39 44.82
Bliss GVS Pharma 133.00 638.96 605.46 20.31 11.19
Ambalal Sarabhai 37.52 11.70 3.81 34.74 1.92